Share on Facebook
Share on Twitter
Share on LinkedIn

When the Food and Drug Administration won a landmark lawsuit this week against a stem cell company, health officials hailed it as a turning point in the government’s struggle to regulate a booming industry selling unproven treatments to desperate patients.

Read More